维普中文期刊产品整合服务
50篇 您的检索式:作者名="Ferlitsch"
    题名 作者 年代 出处 被引量
1Nonselective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis显示文摘T. Reiberger A. Ferlitsch B.A. Payer M. Mandorfer B.B. Heinisch H. Hayden F. Lammert M. Trauner M. Peck-Radosavljevic H. Vogelsang 2012Journal of Hepatology2012,,:5
2Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline显示文摘Cesare Hassan Enrique Quintero Jean-Marc Dumonceau Jaroslaw Regula Catarina Brand?o Stanislas Chaussade Evelien Dekker Mario Dinis-Ribeiro Monika Ferlitsch Antonio Gimeno-García Yark Hazewinkel Rodrigo Jover Mette Kalager Magnus Loberg Christian Pox Bjorn 2013Endoscopy2013,,10:3
3Non-selective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis显示文摘Mattias Mandorfer Simona Bota Philipp Schwabl Theresa Bucsics Nikolaus Pfisterer Matthias Kruzik Michael Hagmann Alexander Blacky Arnulf Ferlitsch Wolfgang Sieghart Michael Trauner Markus Peck-Radosavljevic Thomas Reiberger 2014Gastroenterology2014,,:3
4Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol显示文摘Thomas Reiberger Gregor Ulbrich Arnulf Ferlitsch Berit Anna Payer Philipp Schwabl Matthias Pinter Birgit B Heinisch Michael Trauner Ludwig Kramer Markus Peck-Radosavljevic 2013Gut2013,,11:2
5Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis显示文摘Monika Ferlitsch Thomas Reiberger Matthias Hoke Petra Salzl Bernadette Schwengerer Gregor Ulbrich Berit Anna Payer Michael Trauner Markus Peck‐Radosavljevic Arnulf Ferlitsch 2012Hepatology2012,,4:2
6Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement显示文摘K. Reinhart C. Bannert D. Dunkler P. Salzl M. Trauner F. Renner P. Knoflach A. Ferlitsch W. Weiss M. Ferlitsch 2013Endoscopy2013,,05:2
7Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic pa- tients with haemodynamic non-response to propranolol显示文摘Reiberger T Ulbrich G Ferlitsch A 2013Gut2013,62,11:1
8Effect of virtual endoscopy simulator training on performance of upper gastrointestinal endoscopy in patients: a randomized controlled trial显示文摘A. Ferlitsch R. Schoefl A. Puespoek W. Miehsler M. Schoeniger-Hekele H. Hofer A. Gangl M. Homoncik 2010Endoscopy2010,,12:1
9Hospitalization, fre- quency of interventions, and quality of life after endoscop- ic,surgical, or conservative treatment in patients with chro- nic pancreatitis显示文摘Rutter K Ferlitsch A Sautner T 2010World J Surg2010,34,11:1
10Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites显示文摘Arnulf Ferlitsch Johannes Pleiner Friedrich Mittermayer Georg Schaller Monika Homoncik Markus Peck-Radosavljevic Michael Wolzt 2005Critical Care Medicine2005,,9:1
11Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites 显示文摘Ferlitsch A Pleiner J Mittermayer F 2005Crit Care Med2005,33,9:1
12Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma 显示文摘Ferlitsch A Kreil A Bauer E 2004Eur J Clin Invest2004,34,3:1
13Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol显示文摘REIBERGER T ULBRICH G FERLITSCH A 2013Gut2013,62,11:1
14Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol显示文摘Thomas Reiberger Gregor Ulbrich Arnulf Ferlitsch Berit Anna Payer Philipp Schwabl Matthias Pinter Birgit B Heinisch Michael Trauner Ludwig Kramer Markus Peck-Radosavljevic 2013Gut2013,,11:1
15Body mass index,follicle-stimulating hormone and their predictive value in in vitro fertilization显示文摘Ferlitsch K Sator MO Gruber DM 2004J Assist Reprod Genet2004,21,:1
16Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection显示文摘Reiberger T Rutter K Ferlitsch A 2011Clin Gastroenterol Hepatol2011,9,7:1
17von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis 显示文摘Ferlitsch M Reiberger T Hoke M 2012Hepatology2012,56,4:1
18Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation显示文摘Ferlitsch A Oesterreicher C Dumonceau JM 2001Endoscopy2001,33,8:1
19Carvedilol tbr primary prophylaxis of variceal bleeding in cirrhotic patients with haemody- namic non-response to propranolol 显示文摘Reiberger T Ulbrich G Ferlitsch A 2013Gut2013,62,11:1
20Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients显示文摘Mattias Mandorfer Thomas Reiberger Berit A. Payer Arnulf Ferlitsch Florian Breitenecker Maximilian C. Aichelburg Barbara Obermayer-Pietsch Armin Rieger Michael Trauner Markus Peck-Radosavljevic 2013AIDS2013,,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费